APP and Alzheimer disease: Our RNA sequencing, IHC, and Western blot findings all support the idea that activated astrocytes play a key role in the loss of functional hyperemia, transient ischemia, cerebral inflammation, and loss of cognitive function in the APP/PS1 TgF344-AD rats.